Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
3.3
2.8
Journals
Current Oncology
Announcements
share announcement

Announcements

13 October 2023
Current Oncology | Top Cited Papers in 2021 in the Section “Medical Oncology”

As Current Oncology (ISSN: 1718-7729) is of an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2021 top cited papers in the Section “Medical Oncology” listed below:

1. “Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome”
by Sim Vermeulen, Gil Awada, Marleen Keyaerts, Bart Neyns and Hendrik Everaert
Curr. Oncol. 2021, 28(3), 1630–1640; https://doi.org/10.3390/curroncol28030152
Available online: https://www.mdpi.com/1718-7729/28/3/152

2. “The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial Design”
by Deanna Saunders, Michelle Liu, Lisa Vandermeer, Mashari Jemaan Alzahrani, Brian Hutton and Mark Clemons
Curr. Oncol. 2021, 28(5), 3959–3977; https://doi.org/10.3390/curroncol28050337
Available online: https://www.mdpi.com/1718-7729/28/5/337

3. “Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario”
by Dalia Kamel, Veronica Youssef, Wilma M. Hopman and Mihaela Mates
Curr. Oncol. 2021, 28(3), 2190–2198; https://doi.org/10.3390/curroncol28030203
Available online: https://www.mdpi.com/1718-7729/28/3/203

4. “Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice”
by Joyce O’Shaughnessy, Leisha A. Emens, Stephen Y. Chui, Wei Wang, Kenneth Russell, Shih-Wen Lin, Carlos Flores Avile, Patricia Luhn and Andreas Schneeweiss
Curr. Oncol. 2021, 28(4), 2741–2752; https://doi.org/10.3390/curroncol28040239
Available online: https://www.mdpi.com/1718-7729/28/4/239

5. “18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center”
by Ur Metser, Claudia Ortega, Douglas Hussey, Rosanna Chan, Alejandro Berlin, Antonio Finelli and Patrick Veit-Haibach
Curr. Oncol. 2021, 28(5), 3251–3258; https://doi.org/10.3390/curroncol28050282
Available online: https://www.mdpi.com/1718-7729/28/5/282

6. “The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group”
by Kelvin K. W. Chan, Matthew C. Cheung, Dean A. Regier, Annette Hay, Alexander V. Louie, Winson Y. Cheung, Jean-Eric Tarride, Suji Udayakumar and Nicole Mittmann
Curr. Oncol. 2021, 28(5), 3649–3658; https://doi.org/10.3390/curroncol28050311
Available online: https://www.mdpi.com/1718-7729/28/5/311

7. “Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes”
by Sarah Sharman Moser, Jair Bar, Inna Kan, Keren Ofek, Raanan Cohen, Nikhil Khandelwal, Varda Shalev, Gabriel Chodick and Nava Siegelmann-Danieli
Curr. Oncol. 2021, 28(1), 317–331; https://doi.org/10.3390/curroncol28010036
Available online: https://www.mdpi.com/1718-7729/28/1/36

8. “Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group”
by Wei Fang Dai, Vanessa Arciero, Erica Craig, Brent Fraser, Jessica Arias, Darryl Boehm, Nevzeta Bosnic, Patricia Caetano, Carole Chambers, Barry Jones et al.
Curr. Oncol. 2021, 28(5), 4174–4183; https://doi.org/10.3390/curroncol28050354
Available online: https://www.mdpi.com/1718-7729/28/5/354

9. “Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise”
by Wei Fang Dai, Erica Craig, Brent Fraser, Alex Chambers, Helen Mai, M. Bryson Brown, Craig C. Earle, William K. Evans, Marc Geirnaert, Marianne Taylor et al.
Curr. Oncol. 2021, 28(6), 4645–4654; https://doi.org/10.3390/curroncol28060392
Available online: https://www.mdpi.com/1718-7729/28/6/392

10. “Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec”
by Jason S. Agulnik, Goulnar Kasymjanova, Carmela Pepe, Manjusha Hurry, Ryan N. Walton, Lama Sakr, Victor Cohen and David Small
Curr. Oncol. 2021, 28(6), 5179–5191; https://doi.org/10.3390/curroncol28060434
Available online: https://www.mdpi.com/1718-7729/28/6/434

More News...
Back to TopTop